Foster & Motley’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Sell
12,919
-820
-6% -$9.8K 0.01% 403
2026
Q1
$82K Sell
13,739
-1,082
-7% -$8.14K ﹤0.01% 395
2025
Q4
$106K Sell
14,821
-1,723
-10% -$13.6K 0.01% 387
2025
Q3
$177K Sell
16,544
-5,211
-24% -$51.1K 0.01% 391
2025
Q2
$211K Sell
21,755
-3,590
-14% -$37K 0.01% 382
2025
Q1
$377K Sell
25,345
-354
-1% -$5.44K 0.02% 307
2024
Q4
$383K Sell
25,699
-1,308
-5% -$21.3K 0.02% 305
2024
Q3
$517K Sell
27,007
-1,227
-4% -$25.4K 0.03% 272
2024
Q2
$584K Sell
28,234
-1,121
-4% -$22.3K 0.04% 254
2024
Q1
$552K Sell
29,355
-3,756
-11% -$64.5K 0.04% 254
2023
Q4
$477K Sell
33,111
-3,860
-10% -$52.5K 0.04% 269
2023
Q3
$642K Sell
36,971
-5,735
-13% -$120K 0.05% 241
2023
Q2
$889K Sell
42,706
-9,821
-19% -$213K 0.07% 231
2023
Q1
$1.24M Buy
52,527
+19,030
+57% +$511K 0.1% 192
2022
Q4
$936K Buy
33,497
+1,465
+5% +$37.5K 0.08% 224
2022
Q3
$750K Buy
32,032
+16,406
+105% +$495K 0.07% 215
2022
Q2
$527K Buy
15,626
+8,315
+114% +$291K 0.05% 251
2022
Q1
$255K Buy
+7,311
New +$250K 0.02% 326

Other funds holding OGN

Foster & Motley's OGN Position: Q2 2026 in Review

Foster & Motley reduced its Organon & Co (OGN) stake by 6% in Q2 2026, selling an estimated $9.8K and leaving 12,919 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #403.

Foster & Motley first reported a position in OGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.24M in Q1 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Foster & Motley held 12,919 shares of Organon & Co worth $175K as of Q2 2026.
  • Foster & Motley sold 820 Organon & Co shares in Q2 2026, an estimated $9.8K.
  • Organon & Co made up 0.01% of Foster & Motley's portfolio in Q2 2026, its #403 holding.
  • Foster & Motley first reported a position in Organon & Co in Q1 2022 and has held it in 18 quarters since.
  • Foster & Motley's Organon & Co position peaked at $1.24M in Q1 2023.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.